The shortage of organ donors has impeded the development of human hepatocyte transplantation. Immortalized hepatocytes could provide an unlimited supply of transplantable cells. To determine whether immortalized hepatocytes could provide global metabolic support in end-stage liver disease, rat hepatocyte clones were developed by transduction with the gene encoding the Simian virus 40 T antigen (SVT) using the human artificial minichromosome (HAC). The SVLT sequence was excised by FRT recombination. Following HAC infusion, the transduced hepatocytes express SVT, blasticidine resistance (BS), and the PGK promoter TK gene. Forty-six cell clones were obtained and at least partially characterized, as previously described, for albumin, α-1-antitrypsin, glucose-6-phosphatase (G6Pase), dipeptidylpeptidase 4 (Dpp4), γglutamyltransferase 1 (Ggt), SVT, and β-actin expression using RT-PCR. Clones were also assessed for albumin secretion into the culture medium using ELISA. All of the cell line secreted approximately 10 mg/ dl of albumin, which is equivalent to the amount secreted by primary hepatocytes. In further experiments, this cell line will be used for transplantable cells or artificial organ using HAC. These results represent an important step toward the development of immortalized hepatocytes.
INTRODUCTION
tissue culture and then function as differentiated, nontransformed hepatocytes following transplantation (18, 20) . Such cells could potentially provide an unlimited supply Liver transplantation improves the survival and quality of life for patients with life-threatening liver diseases.
of well-characterized, pathogen-free liver cells. Transplantation of immortalized rat hepatocytes has previously Because of its technical complexity, however, the procedure is associated with significant morbidity and mortal-been shown to provide metabolic support in inherited hepatic disorders and to protect against hyperammo-ity. Studies in animal models indicate that transplantation of isolated hepatocytes could be useful in the nemia-induced hepatic encephalopathy in rats with portasystemic shunts (16, 19) . treatment of patients with liver-based metabolic diseases and liver failure (1, 3, 4, 10, 11, 14, 15, 18, 21) . Because he-To address this issue, rat hepatocytes were conditionally immortalized by transduction using the gene encod-patocytes can be transplanted by minimally invasive percutaneous techniques (6), the risks are relatively low and ing the simian virus T antigen (SVT) and the human artificial minichromosome (HAC). the procedure could be applied to patients who are not candidates for whole organ transplantation.
This method has many advantages in comparison to other methods using virus or other vectors. Primarily, Unfortunately, the number of donated livers available for human hepatocyte isolation is limited by the demand the presence of HAC in the resultant cell line was stable and there was no damage to the host genome. However, on these organs for use in whole organ transplantation. An attractive alternative source of transplantable hepato-this method has never been used to make immortalized hepatocytes. cytes could be cells derived from an immortalized hepatocyte cell line. Immortalized hepatocytes could grow in
The results represent an important step toward the 166 development of immortalized hepatocytes that are safe for 5 min, then resuspended in serum-free DMEM and collected by centrifugation. Microcells were suspended and can function, following transplantation, to treat endstage liver disease.
with rat hepatocyte cells in serum-free D-MEM and centrifuged at 1,500 rpm for 5 min. The pellet was sus-MATERIALS AND METHODS pended in 1 ml 30% PEG1500 (Roche Applied Science) Animals and Chemicals and incubated at room temperature for 90 s. Four milliliters of serum-free DMEM was added and the mixture Inbred male Lewis rats (150-250 g) were obtained was centrifuged at 1,000 rpm for 5 min. The fused cells from Chuubu-kagagu-shizai, Nagoya, Japan and mainwere washed twice in serum-free D-MEM and were tained in the Animal Resource Facility of the Fujitaplated. After 48 h, the medium was changed to DMEM Health University. Animals were maintained on standard supplemented with 2 mg/ml blasticidin S for selection laboratory chow on with a 12-h light/dark cycle. All proof HAC-containing rat hepatocyte cells (Fig. 2 ). cedures performed on rats were approved by the Fujita-Health University Institutional Animal Care and Use Fluorescent In Situ Hybridization (FISH) Committee and were within the guidelines for humane FISH was carried out according to conventional procare of laboratory animals.
cedures (9). For the detection of HACs, biotin-labeled Isolation of Lewis Rat Hepatocytes a21-I alphoid DNA (5,11) and digoxigenin-labeled pBelo-BAC were used as probes. Hepatocytes from Lewis rats were isolated by an in situ two-step collagenase (type IV, Sigma Chemical Co.,
RT-PCR St. Louis) perfusion technique introduced by Berry and
Total RNA was extracted using the SV Total RNA Friend (2) and modified by Seglen (17). Cell viability Isolation System (Promega). cDNA was synthesized uswas, consistently, between 85% and 90%, as determined ing the Transcriptor First Strand cDNA Synthesis Kit by trypan blue exclusion.
(Roche Applied Science). PCR reactions were performed Construction of Human Artificial Minichromosome with Faststart Taq polymerase (Roche Applied Science) (HAC) Containing SV40 T Antigen Gene in CHO Cells using the following conditions: 30 cycles consisting of 95°C for 15 s, 60°C for 15 s, 72°C for 45 s for amplifi-A HAC was constructed using a bottom-up strategy cation of rAlb, rAfp, ratrp, and rG6Pase; 30 cycles conbased on the transfection of cloned centromeric alphoid sisting of 95°C for 15 s, 60°C for 15 s, 72°C for 60 s for DNA precursors into the human cultured cell line amplification of rDpp4 and rGpt; 30 cycles consisting of HT1080 (7). To provide a platform for gene insertion 95°C for 15 s, 55°C for 10 s, 72°C for 30 s for amplifion the HAC, a HAC containing Cre/lox recombination cation of actin; 25 cycles consisting of 95°C for 15 s, sites was constructed using the cotransfection of alphoid 65°C for 20 s, 72°C for 30 s for amplification of SVT. precursors with Cre/lox recombination cassettes (8).
The PCR primers used are shown in Table 1 . Next, a Flp/FRT cassette was inserted into one of the Cre/lox sites on the HAC. As a result, the single Flp/ Medium Albumin Levels and Total Bilirubin Levels FRT insertion site was provided on the HAC. The HAC Samples were obtained from culture medium at varicontaining gene insertion site was transferred from ous time points. The albumin levels were measured us-HT1080 to CHO cells by whole cell fusion and MMCT.
ing a turbidimetric immunoassay. The β-actin-SVT and PGK-TK gene was inserted in the FRT site on the HAC using blasticidine resistance as RESULTS provided by the transient expression of flp recombinase Morphological Assessment in CHO cells containing HAC (Fig. 1) .
While in culture, the morphological appearance of Microcell-Mediated Cchromosome Transfer (MMCT) immortalized cells was observed using a microscope. CHO cells harboring a HAC were grown to 80% con-When primary hepatocytes and immortalized hepatofluence and colcemid was added at a concentration of cytes were observed after 3 days in culture no difference 0.05 mg/ml. The cells were cultured for 48 h and then in their morphology could be detected (Fig. 3 ). harvested. Cells were resuspended in serum-free DMEM Establishment of Immortalized Cell Lines containing cytochalasin B at a final concentration of 20 mg/ml. The suspension was incubated for 5 min at 37°C
Following HAC fusion, transduced hepatocytes expressing SVT colonies emerged in 2 weeks and individ-and then an equal volume of Percoll (Amersham Biosciences) was added. The suspension was centrifuged in a ual colonies were isolated using cloning rings, blasticidine resistance (BS), and PGK promoter TK gene. Hitachi R20A2 rotor at 15,000 rpm for 90 min at 37°C. Microcells were collected by centrifugation at 2,000 rpm Forty-six cell clones were obtained and at least par- albumin, which is equivalent to the amount secreted by primary hepatocytes (Fig. 6 ).
Gene Primer Sequence

DISCUSSION
Previous studies have shown that transplantation of rat hepatocytes, with a SV40 large T antigen, provides not have been expressed in clones and failed to correct encephalopathy. Studies have shown that in vitro evidence of liver-specific function can be dramatically affected by culture conditions and for oncogene-trans-tially characterized, as previously described, and assayed for albumin, α-1-antitrypsin, G6Pase, Dpp4, Ggt, formed cells, and differentiated cellular functions have been shown to improve by serially passaging the cells SVT, and β-actin expression by RT-PCR (Fig. 4) . The results were identical to normal hepatocytes.For the de-in animals (5,13). An analysis of such issues will require further investigation. The fact that pretransplantation tection of HACs, biotin-labeled a21-I alphoid DNA (5,11) and digoxigenin-labeled pBelo-BAC were used as measures of liver-specific function may not correlate with the ability to reverse hepatic encephalopathy will probes for FISH. HACs were detected in all cell lines (Fig. 5) .
be an important consideration in screening other cell lines, such as differentiated embryonic stem cells, for Clones were also assessed for albumin secretion into the culture medium using a turbidimetric immunoassey. clinical application. In summary, the data presented here demonstrate that All of the cell lines secreted approximately 10 mg/dl of diseases.
Biotechnology 10:1112-1120; 1992. 14. Ribeiro, J.; Nordlinger, B.; Ballet, F.; Cynober, L.;
